Overview
Gastrointestinal stromal tumor (GIST) is the most common mesenchymal malignancy of the gastrointestinal tract and serves as a model for targeted therapy development 1. The advent of tyrosine kinase inhibitors targeting KIT/PDGFRA has significantly improved survival in both localized and advanced GIST 1.Diagnosis
Management
Key Recommendations
References
1 Serrano C, Álvarez R, Carrasco JA, Marquina G, Martínez-García J, Martínez-Marín V et al.. SEOM-GEIS clinical guideline for gastrointestinal stromal tumors (2022). Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2023. link